Author

Kingsley Wu

University of California, Riverside

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:mechanistic / dynamical model· 1 Research Focus:protein folding & dynamics· 1 Approach:statistical model· 1

Frequent Co-Authors

Chia‐en A. ChangiD· 1 shared Eslam E. Abd El-FattahiD· 1 shared Karen Saida AboodyiD· 1 shared Mohamed HammadiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Chia‐en A. ChangORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CACNA1C as a Prognostic Biomarker and Therapeutic Target in High-Grade Serous Ovarian Cancer: Clinical Validation and Molecular Dynamics of Nifedipine Blockade

Mohamed Hammad, Kingsley Wu, Eslam E. Abd El-Fattah, Karen Saida Aboody, Chia‐en A. Chang

This paper identifies CACNA1C as a prognostic biomarker and therapeutic target in high-grade serous ovarian cancer, showing nifedipine suppresses tumor growth through calcium channel blockade.

bioRxiv · Apr 22, 2026 · PreprintCancer Biology